Event Date: May 10, 2017



Related Resources l Recording

This presentation will ask (and answer) the following questions: 

1. Is frailty a risk for dementia? 

2. Is it important that frailty is a risk for dementia?

3. How should we approach dementia diagnosis in a person who is frail?
  • Do they have a memory problem?
  • Does it meet dementia criteria?
  • What is the cause?
  • What can we do?

4. Are there special considerations in diagnosing dementia in a person who is frail?  
  • Delirium is more common
  • Mobility impairment is more common
  • Competing factors that exacerbates cognitive impairment are more common (e.g. Anticholinergic drug burden which includes factors that increase risk to for example cardiovascular disease).

Management needs to take various factors into account, which can modify the response to treatment, make adverse effects more likely and increase caregiver burden.  All this mandates team-based systematic care.

This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium of Neurodegeneration in Aging (CCNA). 

                                
 

Related Documents:

Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.

Age-related deficit accumulation and the risk of late-life dementia.

Age-related deficit accumulation and the risk of late-life dementia (full article)

Presenter(s):

Dr. Kenneth Rockwood MD, FRCPC, FRCP, Professor of Medicine

Ken-Rockwood.png

Dr. Kenneth Rockwood is a professor of medicine (geriatric medicine and neurology) at Dalhousie, and an active staff physician. He is also the Kathryn Allen Weldon Professor of Alzheimer Research at Dalhousie University. A native of Newfoundland, he received his MD from Memorial University, and completed internal medicine training at the University of Alberta and geriatric medicine at Dalhousie University. Currently, he is a member of the Canadian Collaboration on Neurodegeneration and Chairs its Quality of Life Theme and the Knowledge Translation Program.